We are live on ! Find out more
MBIO icon

Mustang Bio

36 hedge funds and large institutions have $15.8M invested in Mustang Bio in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 6

0% more funds holding

Funds holding: 3636 (0)

0% more ownership

Funds ownership: 0.01%0.01% (+0%)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

12% less capital invested

Capital invested by funds: $17.9M → $15.8M (-$2.09M)

Holders
36
Holders Change
Holders Change %
0%
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
12
Reduced
6
Closed
5
Calls
$215K
Puts
Net Calls
+$215K
Net Calls Change
-$34K

MBIO Hedge Fund Activity: Q3 2018 in Review

36 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q3 2018, worth a combined $15.8M — down 12% from $17.9M a quarter earlier.

Fund positioning in MBIO was balanced in Q3 2018: 5 funds opened new positions, 5 closed out, 12 added to existing stakes and 6 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $315K. The largest seller was Goldman Sachs, exiting entirely with an estimated $378K sold.

  • 36 institutional investors held Mustang Bio (MBIO) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $15.8M of Mustang Bio stock for Q3 2018, down 12% quarter-over-quarter.
  • 5 funds opened new Mustang Bio positions in Q3 2018 and 5 closed out, a net change of 0 holders.
  • The largest Mustang Bio buyer in Q3 2018 was Morgan Stanley, an estimated $315K added.
  • The largest Mustang Bio seller in Q3 2018 was Goldman Sachs, an estimated $378K sold.

Based on aggregated 13F filings for Q3 2018.